Riskpilot← Back to searchSign inGet full accessMEDIPATH EUROPE AS
ASActiveOrg 925337528Parkveien 12, 0350 OsloEconomic activity was not specified by tax authority · NACE 0000Est. 20200 employees
Revenue 2024
NOK 0
EBITDA margin
—
-494% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -8K
-2% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -9K | -494% |
| Net profit | NOK -8K | -2% |
| Total assets | NOK 36K | +165% |
| Equity | NOK 36K | +165% |
| Employees | 0 | — |
Legal name
MEDIPATH EUROPE AS
Org number
925337528
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
17. juli 2020
Share capital
NOK 49 044
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å tilby tjenester innen helserelatert rådgivning, formidling og tilrettelegging, samt annen virksomhet som står i naturlig sammenheng med dette
Address
Parkveien 12, 0350 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −8 | −1 | −1 | −9 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −8 | −1 | −1 | −9 |
| Net financials | −0 | −0 | −6 | 1 |
| Profit before tax | −8 | −1 | −8 | −8 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −8 | −1 | −8 | −8 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 22 | 21 | 13 | 36 |
| Equity | 22 | 21 | 13 | 36 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 | 0 |
EBITDA margin
-881200.0%
This company
15.8%
Market median
-5577315% vs market
20212024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212024
Return on equity
-22.0%
This company
18.4%
Market median
-220% vs market
20212024
Net profit margin
-783500.0%
This company
8.1%
Market median
-9672940% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-07-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EM Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Chairman | 2025 | |
| Former (3) | ||
| Chairman | 2022 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 64.11% | 64.11% | 2022 | |
| Company | 29.16% | 29.16% | 2022 | |
| Company | 4.49% | 4.49% | 2022 | |
| Company | 2.24% | 2.24% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nicob Holding As
MEDIPATH EUROPE AS Board members of MEDIPATH EUROPE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ellen Marie Solem | Chief Executive Officer | 0 companies |
| Linn Nærup Børke | Chairman | 0 companies |
| Martin Schütt | Board of Directors | 0 companies |
| Martin Lycke | Chairman | 0 companies |
| Kristoffer Ingebrigtsen | Chairman | 0 companies |
| Harald Reigstad Aalvik | Board of Directors | 0 companies |